The IL22RA2 gene makes a protein that acts like a brake on IL-22, an immune signal that affects the lining of the gut, skin, and other barrier tissues. This gene helps your body keep inflammation and tissue repair in balance. If it does not work properly, IL-22 activity may become less controlled, which can contribute to ongoing inflammation. Some variants in the IL22RA2 gene are linked to a higher chance of inflammatory bowel disease, especially ulcerative colitis.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or regulating processes in the body. Some genes carry the information needed to make proteins, which are the working parts of cells. Others mainly control when certain processes happen, where they take place, and how strongly they occur. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To go deeper into this topic, you can find more in the LearnHub.
Overview
IL22RA2Gene function
What if the gene works
The IL22RA2 gene makes a protein that binds IL-22, an immune signal. This helps keep inflammation more controlled, especially in barrier tissues such as the gut, skin, and lungs.
Risk
What if the gene does not work
Milder to more severe variants in the IL22RA2 gene can weaken its protein, which normally binds and tempers IL-22 signaling. This may leave signals that help control inflammation less balanced at barrier tissues such as the gut and skin.
Treatment
What does that mean for your treatment
For a pathogenic or loss-of-function variant in the IL22RA2 gene, no IL22RA2-specific treatment or management approach is currently established in clinical guidelines. The IL22RA2 gene is being studied within the IL-22 pathway as a possible biomarker and future drug target in inflammatory bowel disease and some cancers.
Gene function
What if the gene works
In your body, the IL22RA2 gene helps fine tune an immune signal used to care for tissue linings. It makes a protein that floats outside cells and binds IL-22, a messenger active in places like the gut, skin, and airways. This is part of how the IL22RA2 gene helps regulate immune signals at barrier tissues.
The protein from the IL22RA2 gene attaches tightly to IL-22 outside cells. This limits how much IL-22 reaches its main receptor on cells and keeps the message under control.
By holding some IL-22 in reserve, this gene helps set the strength and timing of that signal. That balance supports a measured exchange between immune cells and the cells lining organs.
Normal IL22RA2 activity helps barrier tissues such as the gut, skin, and airways respond in an orderly way to everyday stress. It supports healthy communication linked to lining repair and surface defense.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body reacts to environmental influences. Many do not cause any noticeable effects and simply represent natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the IL22RA2 gene can alter how much protein a cell makes, whether that protein folds into the right shape, and how well it is released outside the cell. In discussing how IL22RA2 gene variants affect protein function, the main effects are often reduced stability or weaker binding to IL-22, a signaling molecule. Some variants are milder and only partly reduce activity, while more severe variants can greatly lower or stop protein production.
How variants are linked to conditions
Variants in the IL22RA2 gene are most clearly linked to ulcerative colitis, a form of inflammatory bowel disease. Research on the IL22RA2 gene and ulcerative colitis shows that some common variants are associated with a modestly higher chance of developing this condition, but they do not make it certain. Some studies have also reported links with Crohn disease, though that association is less consistent.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of human biology and are widely found in the general population. Most do not directly affect health and simply reflect normal human diversity. For many genes, having a variant linked to a condition indicates a possible association rather than a definite diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, a single well characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the IL22RA2 gene itself. Changes in this gene may play a part in inflammatory conditions in some people, but overall risk is also shaped by many other genes and by non-genetic factors.
Inheritance of IL22RA2 variants
There is not yet a broadly confirmed Mendelian pattern for the inheritance of IL22RA2 gene variants tied to a specific human condition. In practice, inheritance of IL22RA2 gene variants is understood mainly in the usual way any autosomal gene is passed through families, rather than as a clearly defined dominant or recessive syndrome. The IL22RA2 gene is located on chromosome 6, which is one of the autosomes. That means you inherit one copy from your mother and one copy from your father.
What does my IL22RA2 result mean for my family?
There isn’t yet a broadly confirmed inheritance pattern tied to a specific condition for IL22RA2, though this understanding can change as research develops. If you have a specific IL22RA2 result and questions about what it could mean for your family, a doctor or genetic counselor can help explain it in the context of your relatives and family history.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for IL22RA2 variants uses a blood sample or cheek swab, and a lab reads the DNA code to look for changes in the IL22RA2 gene. Results can show whether a variant is present, absent, or of uncertain meaning.
When should I consider getting a genetic test?
There is not yet a widely accepted, IL22RA2-specific reason for genetic testing in routine care. Testing decisions are best made with a doctor or genetic counselor, based on your symptoms, health history, and family history.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but what it can tell you depends on the condition and on the type of variant involved. Over time, many factors affect how the body functions, including lifestyle, environment, age, and medical history. For some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and makes the most sense when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put a person’s experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This kind of variation is common. Because of this, the same treatment may work better for some people, have less effect in others, or make some people more sensitive to side effects even when they take the same dose.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medicines. By looking at links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medications, genes can influence both how strongly a drug works and how the body processes it. This understanding can support treatment decisions that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the IL22RA2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose. If you have concerns about side effects, unusual reactions, or whether a treatment is working as expected, discuss them with your doctor or pharmacist.
History
IL22RA2 entered the scientific literature in the early 2000s, when researchers studying immune signaling identified it as a receptor related to the pathway for interleukin 22. It was first described as IL-22 binding protein, which highlighted its unusual role in attaching to this immune messenger outside the cell. From these first observations, research expanded steadily. Scientists then recognized that IL22RA2 helped shape a broader shift in understanding of how the body fine tunes inflammation, not only by activating signals but also by limiting them. Later work linked the gene to inflammatory conditions of the gut and skin, which made it a steady topic in immunology research. While it has not become widely known in public culture, it remains important in the history of modern immune genetics.